Drug Type Small molecule drug |
Synonyms CP 422935, NGD 951, NGD-951 |
Target |
Action antagonists |
Mechanism NPY receptor antagonists(Neuropeptide Y receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bulimia Nervosa | Phase 1 | United States | - | - |
| Bulimia Nervosa | Phase 1 | - | - | |
| Feeding and Eating Disorders | Phase 1 | United States | - | - |
| Obesity | Phase 1 | United States | - | - |
| Obesity | Phase 1 | - | - |





